Workflow
Revenue Projections
icon
Search documents
Curious about Alignment Healthcare (ALHC) Q4 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2026-02-25 15:15
Analysts on Wall Street project that Alignment Healthcare (ALHC) will announce quarterly loss of -$0.15 per share in its forthcoming report, representing an increase of 6.3% year over year. Revenues are projected to reach $1 billion, increasing 42.9% from the same quarter last year.The consensus EPS estimate for the quarter has undergone an upward revision of 16.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial esti ...
Exploring Analyst Estimates for RadNet (RDNT) Q4 Earnings, Beyond Revenue and EPS
ZACKS· 2026-02-25 15:15
The upcoming report from RadNet (RDNT) is expected to reveal quarterly earnings of $0.19 per share, indicating a decline of 13.6% compared to the year-ago period. Analysts forecast revenues of $515.37 million, representing an increase of 8% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company announces its earnings, ...
What Analyst Projections for Key Metrics Reveal About Jazz (JAZZ) Q4 Earnings
ZACKS· 2026-02-19 15:16
Wall Street analysts forecast that Jazz Pharmaceuticals (JAZZ) will report quarterly earnings of $6.62 per share in its upcoming release, pointing to a year-over-year increase of 0.3%. It is anticipated that revenues will amount to $1.18 billion, exhibiting an increase of 8.4% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 13% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have re ...
Ahead of FMC Technologies (FTI) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2026-02-18 15:16
Core Viewpoint - Analysts expect FMC Technologies (FTI) to report quarterly earnings of $0.51 per share, reflecting a year-over-year decline of 5.6%, while revenues are projected to be $2.55 billion, an increase of 7.6% from the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.4% higher in the last 30 days, indicating a collective reevaluation by analysts [1][2] Revenue Projections - Revenue from Subsea Technologies is expected to reach $2.23 billion, marking an 8.7% increase year-over-year [4] - Revenue from Surface Technologies is projected at $322 million, reflecting a 0.8% increase from the prior year [4] - Revenue from Lease is estimated at $71.31 million, indicating a significant increase of 24% year-over-year [4] - Revenue from Product is anticipated to be $922.80 million, showing an 8.3% increase from the previous year [5] Geographic Revenue Estimates - Revenue from Surface Technologies in Europe and Central Asia is expected to be $33.62 million, a 13.2% increase year-over-year [5] - Revenue from Surface Technologies in Africa is projected at $15.95 million, reflecting a 24.6% increase [6] - Revenue from Surface Technologies in North America is estimated at $105.63 million, indicating a decline of 1.6% from the prior year [6] - Revenue from Surface Technologies in the Middle East is expected to be $118.75 million, reflecting a decrease of 5% year-over-year [7] Order Backlog and Inbound Orders - The Order Backlog for Subsea Technologies is estimated at $16.31 billion, up from $13.52 billion year-over-year [8] - The total Order Backlog is projected to reach $17.06 billion, compared to $14.38 billion a year ago [8] - The Order Backlog for Surface Technologies is expected to be $728.81 million, down from $858.20 million year-over-year [8] - Inbound Orders for Subsea Technologies are forecasted to be $2.45 billion, down from $2.70 billion in the same quarter last year [7] Stock Performance - FMC Technologies shares have shown a return of +17.4% over the past month, outperforming the Zacks S&P 500 composite, which declined by -1.3% [10]
Unlocking Q4 Potential of Skyward (SKWD): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2026-02-18 15:15
The upcoming report from Skyward Specialty Insurance (SKWD) is expected to reveal quarterly earnings of $0.93 per share, indicating an increase of 16.3% compared to the year-ago period. Analysts forecast revenues of $374 million, representing an increase of 22.9% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 2.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimate ...
Exploring Analyst Estimates for Advanced Drainage (WMS) Q3 Earnings, Beyond Revenue and EPS
ZACKS· 2026-02-04 15:15
Core Viewpoint - Analysts project that Advanced Drainage Systems (WMS) will report quarterly earnings of $1.11 per share, reflecting a year-over-year increase of 1.8%, while revenues are expected to decline by 0.6% to $686.55 million [1] Earnings Projections - The consensus EPS estimate for the quarter has been revised upward by 0.7% over the past 30 days, indicating a collective reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Key Metrics Forecast - Analysts estimate 'Adjusted Gross Profit- Pipe' at $96.85 million, up from $90.90 million in the same quarter last year [5] - The forecast for 'Adjusted Gross Profit- International' is $11.40 million, down from $12.07 million year-over-year [5] - 'Adjusted Gross Profit- Allied Products & Other' is expected to be $94.15 million, compared to $92.94 million in the previous year [6] - 'Adjusted Gross Profit- Infiltrator' is projected at $80.65 million, an increase from $78.29 million in the same quarter last year [6] Stock Performance - Shares of Advanced Drainage have returned +4.6% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.9% change [6] - With a Zacks Rank 3 (Hold), WMS is anticipated to reflect overall market performance in the near future [6]
Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2026-01-30 15:20
Core Viewpoint - Analysts forecast that Boston Scientific (BSX) will report quarterly earnings of $0.78 per share, reflecting an 11.4% year-over-year increase, with revenues expected to reach $5.27 billion, a 15.4% increase compared to the previous year [1]. Earnings Estimates - Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter, indicating stability in analysts' forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong relationship between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts predict 'Net Sales- MedSurg- Worldwide' will reach $1.80 billion, indicating an 11.5% year-over-year change [5]. - The consensus estimate for 'Net Sales- Cardiovascular- Worldwide' stands at $3.46 billion, reflecting a 17.5% increase from the year-ago quarter [5]. - 'Net Sales- MedSurg- Urology- Worldwide' is expected to be $725.74 million, showing a 15.2% year-over-year change [5]. - 'Net Sales- MedSurg- Endoscopy- Worldwide' is forecasted to reach $756.05 million, indicating a 9.6% increase from the previous year [6]. - 'Geographic Revenue- Rest of the World' is projected to be $1.88 billion, reflecting a 12.4% year-over-year change [6]. - 'Geographic Revenue- U.S.' is expected to reach $3.39 billion, indicating a 17% increase [6]. - 'Net Sales- Cardiovascular- Peripheral Interventions- International' is estimated at $297.57 million, suggesting an 11% year-over-year change [7]. - 'Net Sales- MedSurg- Neuromodulation- United States' is projected to be $247.55 million, reflecting a 7.2% increase [7]. - 'Net Sales- MedSurg- Neuromodulation- International' is expected to be $75.13 million, indicating a 10.5% year-over-year change [8]. - 'Net Sales- MedSurg- Endoscopy- United States' is forecasted to reach $462.66 million, reflecting a 9.4% increase [8]. - 'Net Sales- MedSurg- Endoscopy- International' is projected at $293.49 million, indicating a 9.9% year-over-year change [9]. - 'Net Sales- MedSurg- Urology- United States' is expected to be $545.86 million, reflecting an 18.9% increase from the previous year [9]. Stock Performance - Over the past month, shares of Boston Scientific have returned -3.2%, while the Zacks S&P 500 composite has changed by +0.9% [9]. - Currently, BSX carries a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [9].
Countdown to SEI (SEIC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2026-01-27 15:15
Core Viewpoint - Analysts expect SEI Investments (SEIC) to report quarterly earnings of $1.34 per share, reflecting a year-over-year increase of 12.6%, with revenues projected at $595.79 million, up 6.9% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.9% higher over the last 30 days, indicating a collective reevaluation by analysts [1][2]. Revenue Projections - Revenue from Asset management, administration, and distribution fees is expected to be $472.28 million, a 7.5% increase year-over-year [4]. - Revenue from Information processing and software servicing fees is projected at $123.71 million, reflecting a 5.1% increase from the prior year [4]. - Revenue from Private Banks is anticipated to be $147.29 million, also a 5.1% increase from the previous year [5]. - Revenue from Investments in New Business is expected to decline to $9.59 million, a significant decrease of 38.9% year-over-year [5]. Assets Under Management - Assets under management for Investments in New Business are estimated at $3.16 billion, up from $3.04 billion year-over-year [5]. - Assets under management for Investment Advisors are projected to reach $97.05 billion, compared to $79.39 billion last year [6]. - Assets under management for Private Banks are expected to be $31.45 billion, an increase from $28.22 billion year-over-year [6]. - Institutional Investors' assets under management are forecasted to be $85.14 billion, up from $76.99 billion in the same quarter last year [7]. - Assets under management for LSV - Equity and Fixed Income programs are estimated at $82.09 billion, down from $86.50 billion year-over-year [7]. - Total assets under management for Investment Managers are projected to reach $240.47 billion, up from $202.57 billion last year [8]. Client Assets Under Administration - Client assets under administration for Investment Managers are expected to reach 1,223,549, compared to 1,032,812 in the previous year [8]. - Client assets under administration for Private Banks are projected to be 8,713, an increase from 8,340 year-over-year [9]. Stock Performance - Over the past month, SEI shares have returned +1.5%, outperforming the Zacks S&P 500 composite's +0.4% change, indicating a positive outlook for the stock [10].
Ahead of Visa (V) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2026-01-26 15:15
Core Viewpoint - Analysts forecast that Visa will report quarterly earnings of $3.14 per share, reflecting a year-over-year increase of 14.2%, with revenues expected to reach $10.69 billion, an increase of 12.4% compared to the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to stock performance, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [2] Key Metrics Projections - Analysts estimate 'Revenues- Service revenue' at $4.68 billion, indicating a year-over-year change of +11.2% [4] - The average prediction for 'Revenues- Data processing revenue' is $5.44 billion, reflecting a year-over-year change of +14.6% [4] - 'Revenues- Other revenue' is projected to be $1.09 billion, showing a change of +19.4% from the previous year [4] International and Total Payments Volume - 'Revenues- International transaction revenue' is expected to reach $3.85 billion, suggesting a year-over-year increase of +11.8% [5] - 'End of Period Connections - Total transactions' is projected to be 69.85 billion, up from 63.80 billion year-over-year [5] - 'Payments volume - Total' is forecasted to reach $3828.52 billion, compared to $3522.00 billion in the previous year [5] Regional Payments Volume - 'Payments volume - Canada' is estimated at $117.01 billion, up from $111.00 billion in the same quarter last year [6] - 'Payments volume - CEMEA' is projected at $244.88 billion, compared to $211.00 billion in the same quarter of the previous year [6] - 'Payments volume - LAC' is expected to reach $277.20 billion, compared to $242.00 billion year-over-year [7] - 'Payments volume - U.S.A' is estimated at $1834.14 billion, up from $1720.00 billion in the same quarter last year [8] - 'Payments volume - Europe' is projected to be $798.70 billion, compared to $714.00 billion in the previous year [8] Stock Performance - Visa shares have shown a return of -8.1% over the past month, while the Zacks S&P 500 composite has increased by +0.2%, with Visa expected to mirror the overall market performance in the near future [8]
Unlocking Q4 Potential of Corning (GLW): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2026-01-23 15:15
Core Insights - Analysts project Corning (GLW) will report quarterly earnings of $0.70 per share, reflecting a 22.8% year-over-year increase, with revenues expected to reach $4.32 billion, an 11.6% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' assessments [1][2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [2] Key Metrics Forecast - Analysts estimate 'Net Sales- Display Technologies' at $880.85 million, a decrease of 9.3% year over year [4] - 'Net Sales- Hemlock and Emerging Growth Businesses' is projected at $464.86 million, an increase of 24.6% year over year [4] - 'Net Sales- Specialty Materials' is expected to reach $587.56 million, indicating a 14.1% increase from the prior-year quarter [4] Segment Sales and Income - The consensus for 'Net Sales- Life Sciences' is $249.13 million, showing a slight decline of 0.4% year over year [5] - 'Net Sales- Optical Communications' is forecasted at $1.71 billion, reflecting a 24.8% increase from the year-ago quarter [5] - 'Segment Net Income- Display Technologies' is expected to be $216.95 million, down from $262.00 million in the same quarter last year [5][6] - 'Segment Net Income- Life Sciences' is projected at $17.35 million, compared to $18.00 million a year ago [6] - 'Segment Net Income- Optical Communications' is anticipated to reach $261.29 million, up from $194.00 million last year [6] - 'Segment Net Income- Specialty Materials' is estimated at $98.80 million, compared to $81.00 million in the previous year [7] Stock Performance - Over the past month, Corning's shares have returned +5.2%, outperforming the Zacks S&P 500 composite's +0.6% change [7] - Corning currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [7]